Showing results (71-80 of 437) with videos related to
Sort By:
Pageof 44
Muscle & Nerve|April 14, 2012
Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care planDaniel E Furst, Anthony A Amato, Şerban R Iorga, et al.Journal of Scleroderma and Related Disorders|April 7, 2022
Responsiveness of the University of California Los Angeles Scleroderma Clinical Trial Consortium gastrointestinal tract 2.0 (UCLA-SCTC-GIT 2.0)to change in scleroderma patientsYossra Atef Suliman, Suzanne Kafaja, Mohamed Alemam, et al.Annals of the Rheumatic Diseases|January 26, 2013
Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysisJérôme Avouac, Dörte Huscher, Daniel E Furst, et al.Annals of the Rheumatic Diseases|January 20, 2007
The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosisLászló Czirják, Zoltán Nagy, Martin Aringer, et al.Rheumatology and Therapy|November 23, 2019
Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial DataPaul Emery, Daniel E Furst, Petra Kirchner, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 30, 2008
Oral cyclophosphamide for active scleroderma lung disease: a decision analysisDinesh Khanna, Daniel E Furst, Philip J Clements, et al.Muscle & Nerve|September 19, 2012
Medical costs and health-care resource use in patients with inflammatory myopathies in an insured populationDaniel E Furst, Anthony A Amato, Serban R Iorga, et al.Rheumatology (Oxford, England)|July 23, 2015
Final 10-year effectiveness and safety results from study DE020: adalimumab treatment in patients with rheumatoid arthritis and an inadequate response to standard therapyDaniel E Furst, Arthur Kavanaugh, Stefan Florentinus, et al.Drug Safety|November 8, 2019
Rheumatology Common Toxicity Criteria (RCTC): An Update Reflecting Real-World UseChristian M Stach, Victor S Sloan, Thasia G Woodworth, et al.Rheumatology (Oxford, England)|October 10, 2017
Points to consider when doing a trial primarily involving the heartYannick Allanore, Oliver Distler, Ulrich A Walker, et al.Pageof 44